Foxp3 heterozygosity does not overtly affect mammary gland development during puberty or the oestrous cycle in mice
Date
2020
Authors
Atashgaran, V.
Dasari, P.
Hodson, L.J.
Evdokiou, A.
Barry, S.C.
Ingman, W.V.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Reproduction, Fertility and Development, 2020; 32(8):774-782
Statement of Responsibility
Vahid Atashgaran, Pallave Dasari, Leigh J. Hodson, Andreas Evdokiou, Simon C. Barry, and Wendy V. Ingman
Conference Name
DOI
Abstract
Female mice heterozygous for a genetic mutation in transcription factor forkhead box p3 (Foxp3) spontaneously develop mammary cancers; however, the underlying mechanism is not well understood. We hypothesised that increased cancer susceptibility is associated with an underlying perturbation in mammary gland development. The role of Foxp3 in mammary ductal morphogenesis was investigated in heterozygous Foxp3Sf+ and wildtype Foxp3 +/+ mice during puberty and at specific stages of the oestrous cycle. No differences in mammary ductal branching morphogenesis, terminal end bud formation or ductal elongation were observed in pubertal Foxp3Sf/+ mice compared with Foxp3 +/+ mice. During adulthood, all mice underwent normal regular oestrous cycles. No differences in epithelial branching morphology were detected in mammary glands from mice at the oestrus, metoestrus, dioestrus and pro-oestrus stages of the cycle. Furthermore, abundance of Foxp3 mRNA and protein in the mammary gland and lymph nodes was not altered in Foxp3Sf/+ mice compared with Foxp3 +/+ mice. These studies suggest that Foxp3 heterozygosity does not overtly affect mammary gland development during puberty or the oestrous cycle. Further studies are required to dissect the underlying mechanisms of increased mammary cancer susceptibility in Foxp3Sf/+ heterozygous mice and the function of this transcription factor in normal mammary gland development.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© CSIRO 2020